Company Search:
Advanced Search
Sponsored Links
Moberg Pharma AB (publ) Company Snapshot
Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other pharmaceutical manufacturers in Europe: Lavipharm SA of Greece (2015 sales of 26.37 million Euro [US$28.94 million] ), Horizon Discovery Group PLC of the United Kingdom (£20.16 million [US$24.76 million] of which 60% was Services), and Krasfarma OAO which is based in Russia (1.70 billion Russian Rubles [US$27.29 million] ).

Sales Analysis. Moberg Pharma AB (publ) reported sales of SEK 285.57 million (US$32.32 million) for the year ending December of 2015. This represents an increase of 42.7% versus 2014, when the company's sales were SEK 200.18 million. Sales at Moberg Pharma AB (publ) have increased during each of the previous five years (and since 2010, sales have increased a total of 3,255%). Sales of Other Products saw an increase that was more than double the company's growth rate: sales were up 140.3% in 2015, from SEK 25.36 million to SEK 60.94 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Moberg Pharma AB (publ)
  Stock Performance Chart for Moberg Pharma AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 51.50
(Figures in Swedish Kronor)
1 Week 3.0%   13 Weeks 6.8%  
4 Weeks 28.4%   52 Weeks -4.6%  
Moberg Pharma AB (publ) Key Data:
  Ticker: MOB Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 285,566,000
(Year Ending Jan 2016).
Employees: 33
  Currency: Swedish Kronor Market Cap: 735,893,182
  Fiscal Yr Ends: December Shares Outstanding: 14,289,188
  Share Type: Aktie Closely Held Shares: 4,267,436
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.